7
Participants
Start Date
February 6, 2019
Primary Completion Date
August 28, 2019
Study Completion Date
August 28, 2019
Acetazolamide
Medical therapy including diet
Optic Nerve Sheath Fenestration
Medical therapy including diet + optic nerve sheath fenestration
Ventriculoperitoneal CSF Shunting
Medical therapy including diet + ventriculoperitoneal CSF Shunting
New York Eye & Ear Infirmary of Mount Sinai, New York
New York University School of Medicine, New York
State University of New York at Stony Brook, East Setauket
University of Rochester, Rochester
University of Pennsylvania, Philadelphia
Bethesda Neurology, LLC, North Bethesda
Johns Hopkins University School of Medicine, Baltimore
University of Virginia, Charlottesville
Virginia Commonwealth University, Richmond
University of Miami, Miami
Washington University in St. Louis, St Louis
Vanderbilt University Medical Center, Nashville
University of Kentucky, Lexington
Ohio Neuro-Ophthalmology, Orbital Disease and Oculoplastics, Columbus
University of Iowa, Iowa City
University of Wisconsin, Madison
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Northwestern Medicine, Chicago
University of Illinois at Chicago, Chicago
Saint Louis University, St Louis
University of Kansas School of Medicine, Prairie Village
University of Nebraska Medical Center, Omaha
Dean McGee Eye Institute, Oklahoma City
Neuro-Eye Clinical Trials-Houston, Houston
University of Colorado - Anschutz Medical Campus, Aurora
University of Utah, Salt Lake City
University of Southern California, Los Angeles
NeuroEyeOrbit Institute, Los Angeles
Stanford University, Palo Alto
Swedish Medical Center, Seattle
The Eye Care Group, Orange
Brigham and Women's Hospital, Boston
University of Calgary, Calgary
Sunnybrook Health Science Center, Toronto
Rivera, Enrique J, Bayamón
Lead Sponsor
National Eye Institute (NEI)
NIH
University of Iowa
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Jaeb Center for Health Research
OTHER